z-logo
open-access-imgOpen Access
Recombinant Human Thyrotropin-Aided Radioiodine Therapy in Tracheal Obstruction by an Invading Well-Differentiated Thyroid Carcinoma
Author(s) -
Nickolaos Pontikides,
Spyridon Ν. Karras,
A. Papagiannis,
Athina Kaprara,
Panagiotis Anagnostis,
George Noussios,
Argyrios Doumas,
Apostolos Goropoulos,
Ιoannis Iakovou,
Georgios Kotronis,
Konstantinos Bantis,
Gerasimos E Krassas
Publication year - 2013
Publication title -
case reports in otolaryngology
Language(s) - English
Resource type - Journals
eISSN - 2090-6765
pISSN - 2090-6773
DOI - 10.1155/2013/579527
Subject(s) - radioiodine therapy , medicine , thyroid carcinoma , recombinant dna , thyroid , oncology , endocrinology , biology , biochemistry , gene
Papillary thyroid carcinomas (PTCs) usually extend to lymph nodes in the neck and mediastinum. Rarely, they invade the neighboring upper airway anatomical structures. We report a 56-year-old woman who presented with symptoms of upper airway obstruction. Imaging studies revealed a lesion derived from the thyroid which invaded and obstructed the trachea, which appeared to be a highly differentiated PTC. Total thyroidectomy was performed, with removal of the endotracheal part of the mass along with the corresponding anterior tracheal rings. Two months later, a whole body I 131 scan after recombinant human thyroid-stimulating hormone (rh-TSH) administration was performed and revealed a residual mass in upper left thyroid lobe. Subsequently, 150 mCi I 131 were given following rh-TSH administration. Nine months later, there was no sign of residual tumor. This case is the first one reported in the literature regarding rh-TSH administration prior to RAI ablation in a PTC obstructing the trachea.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom